Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Haemonetics Corporation (HAE)

88.24   -3.42 (-3.73%) 09-26 15:59
Open: 91.52 Pre. Close: 91.66
High: 92.03 Low: 88.23
Volume: 371,424 Market Cap: 4,475(M)

Technical analysis

as of: 2023-09-26 3:50:07 PM
Short-term rate:       
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Mid-term rate:       
Target: Six months: 108.02     One year: 126.17
Support: Support1: 87.44    Support2: 84.33
Resistance: Resistance1: 92.48    Resistance2: 108.02
Pivot: 90.03
Moving Average: MA(5): 90.48     MA(20): 89.88
MA(100): 87.54     MA(250): 83.61
MACD: MACD(12,26): 0.3     Signal(9): 0.3
Stochastic oscillator: %K(14,3): 60.3     %D(3): 65.4
RSI: RSI(14): 46.5
52-week: High: 95.26  Low: 72.19
Average Vol(K): 3-Month: 286 (K)  10-Days: 293 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ HAE ] has closed above bottom band by 23.2%. Bollinger Bands are 42.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 91.98 - 92.43 92.43 - 92.89
Low: 88.78 - 89.25 89.25 - 89.73
Close: 90.9 - 91.65 91.65 - 92.41

Company Description

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Headline News

Tue, 26 Sep 2023
Terumo's (TRUMY) MicroVention Enters Transradial Access Space - Nasdaq

Tue, 26 Sep 2023
Level Four Advisory Services LLC Acquires New Position in ... - MarketBeat

Mon, 25 Sep 2023
Boston Scientific (BSX) Set to Acquire Relievant Medsystems - Nasdaq

Wed, 20 Sep 2023
Nordea Investment Management AB Has $10.92 Million Stock ... - MarketBeat

Tue, 19 Sep 2023
Phibro (PAHC) Sales Impacted by Macro Concerns, FX Headwind - Nasdaq

Tue, 19 Sep 2023
Macquarie Group Ltd. Grows Position in Haemonetics Co. (NYSE ... - MarketBeat

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 51 (M)
Shares Float 50 (M)
% Held by Insiders 0.8 (%)
% Held by Institutions 101.3 (%)
Shares Short 1,580 (K)
Shares Short P.Month 1,390 (K)

Stock Financials

EPS 2.6
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 17.04
Profit Margin (%) 11.2
Operating Margin (%) 15.6
Return on Assets (ttm) 6.2
Return on Equity (ttm) 16.7
Qtrly Rev. Growth 19.1
Gross Profit (p.s.) 0
Sales Per Share 24.05
EBITDA (p.s.) 5.6
Qtrly Earnings Growth 110.5
Operating Cash Flow 250 (M)
Levered Free Cash Flow 170 (M)

Stock Valuations

PE Ratio 34.02
PEG Ratio 2.2
Price to Book value 5.2
Price to Sales 3.69
Price to Cash Flow 18

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.